65,437 trials
HIV Infection · Tuberculosis
Primary: Percent of Participants Who Survived Without AIDS Progression. — 13; 16 percent of participants — p=0.45
Osteoarthritis · Back Pain
Primary: Average Daily Pain Score Box Scale-11 (BS-11) Recorded at Week 12 (Average Pain Over Last 24 Hours) — 4.2; 4.64 Units on a BS-11 scale at Week 12 — p=0.002
Nocturnal Enuresis
Primary: Change in the Number of Wet Nights Between Baseline and Treatment Period II — 3.264; 1.451 wet nights — p=0.009
HIV Infections
Primary: Number of Patients With Human Immunodeficiency Virus Type 1 (HIV-1) Ribonucleic Acid (RNA) Viral Load <50 Copies/mL — 108; 108; 59; 62 participants
Astigmatism
Primary: Visual Acuity After Infero-temporal Version Movement. — 0.12; 0.1; 0.16; 0.14 LogMAR units — p=0.02
Marijuana Abuse
Primary: Proportion of Patients Abstinent From Marijuana During Weeks 7 and 8 of the Trial — 14; 12 participants
Central Nervous System Diseases
Primary: Change in Contrast to Noise Ratio (CNR) Between Pre- and Post-contrast Magnetic Resonance Imaging (MRI) Scan of Central Nervous System (CNS) Lesions — 50.41; 43.47…
Hypercholesterolemia
Primary: Percent Change From Baseline in Low Density Lipoprotein (LDL)-C — -26.81; -11.81 percent change from baseline — p=<0.001
Diabetes Mellitus, Type 2
Primary: HbA1c Change From Baseline at Week 12 — 0.28; -0.46; -0.52 percent — p=<0.0001
Contraception
Primary: Percentage of Applicator Users Who Were Very Satisfied and Satisfied- User Satisfaction Questionnaire for Domain: Design & Technical Aspects — 99.1 Percentage of…
Coronary Artery Disease · Heart Valve Disease
Primary: Amount of Postoperative Bleeding — 868.9; 1467.6 mL
Acne Vulgaris
Primary: Change From Baseline in Inflammatory Lesion Counts (Papules,Pustules, and Nodules) at Week 12 — 38.94; 40.78; -25.77; -24.82 Number of Lesions
Acne Vulgaris
Primary: Change From Baseline in Inflammatory Lesion Counts (Papules, Pustules and Nodules) at Week 12 — 38.96; 40.06; -24.05; -25.82 Number of Lesions
Secondary Hyperparathyroidism · Renal Insufficiency, Chronic · Parathyroid Hormone
Primary: The Percentage of Patients Reaching at Least a 30% Reduction in PTH and/or Values in Range 150-300 pg/mL — 96.6 Percentage of participants
Open Angle Glaucoma · Ocular Hypertension
Primary: Change From Baseline in Mean Conjunctival Hyperemia Scores at Month 3 — 0.74; 0.86; 0.74; 0.05 Scores on Scale